Earm J H, Christensen B M, Frøkiaer J, Marples D, Han J S, Knepper M A, Nielsen S
Department of Cell Biology, Institute of Anatomy and Institute of Experimental Clinical Research, University of Aarhus, Denmark.
J Am Soc Nephrol. 1998 Dec;9(12):2181-93. doi: 10.1681/ASN.V9122181.
Hypercalcemia is frequently associated with a urinary concentrating defect and overt polyuria. The molecular mechanisms underlying this defect are poorly understood. Dysregulation of aquaporin-2 (AQP2), the predominant vasopressin-regulated water channel, is known to be associated with a range of congenital and acquired water balance disorders including nephrogenic diabetes insipidus and states of water retention. This study examines the effect of hypercalcemia on the expression of AQP2 in rat kidney. Rats were treated orally for 7 d with dihydrotachysterol, which produced significant hypercalcemia with a 15 +/- 2% increase in plasma calcium concentration. Immunoblotting and densitometry of membrane fractions revealed a significant decrease in AQP2 expression in kidney inner medulla of hypercalcemic rats to 45.7 +/- 6.8% (n = 11) of control levels (100 +/- 12%, n = 9). A similar reduction in AQP2 expression was seen in cortex (36.9 +/- 4.2% of control levels, n = 6). Urine production increased in parallel, from 11.3 +/- 1.4 to a maximum of 25.3 +/- 1.9 ml/d (P < 0.01), whereas urine osmolality decreased from 2007 +/- 186 mosmol/kg x H2O to 925 +/- 103 mosmol/kg x H2O (P < 0.01). Immunocytochemistry confirmed a decrease in total AQP2 labeling of collecting duct principal cells from kidneys of hypercalcemic rats, and reduced apical labeling. Immunoelectron microscopy demonstrated a significant reduction in AQP2 labeling of the apical plasma membrane, consistent with the development of polyuria. In summary, the results strongly suggest that AQP2 downregulation and reduced apical plasma membrane delivery of AQP2 play important roles in the development of polyuria in association with hypercalcemia.
高钙血症常伴有尿浓缩功能缺陷和明显的多尿。这种缺陷的分子机制尚不清楚。水通道蛋白-2(AQP2)是主要的血管加压素调节水通道,其失调与一系列先天性和获得性水平衡紊乱有关,包括肾性尿崩症和水潴留状态。本研究探讨高钙血症对大鼠肾脏AQP2表达的影响。大鼠口服双氢速甾醇7天,导致显著的高钙血症,血浆钙浓度增加15±2%。对膜组分进行免疫印迹和光密度测定,结果显示高钙血症大鼠肾内髓质中AQP2表达显著降低,降至对照水平(100±12%,n=9)的45.7±6.8%(n=11)。皮质中AQP2表达也有类似程度的降低(降至对照水平的36.9±4.2%,n=6)。尿量同时增加,从11.3±1.4 ml/d增至最高25.3±1.9 ml/d(P<0.01),而尿渗透压从2007±186 mosmol/kg·H2O降至925±103 mosmol/kg·H2O(P<0.01)。免疫细胞化学证实高钙血症大鼠肾脏集合管主细胞的总AQP2标记减少,顶端标记也减少。免疫电子显微镜显示顶端质膜的AQP2标记显著减少,这与多尿的发生一致。总之,结果强烈表明,AQP2下调以及AQP2顶端质膜转运减少在高钙血症相关的多尿发生中起重要作用。